NCT01827904View on ClinicalTrials.gov

ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Essential Tremor
Interventions
DEVICE

Transcranial ExAblate

DEVICE

Sham Transcranial ExAblate

Trial Locations (8)

21201

University of Maryland Medical System, Baltimore

22908

University of Virginia, Charlottesville

94305

Stanford University Medical Center, Stanford

98122

Swedish Medical Center, Seattle

02115

Brigham and Women's Hospital, Boston

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

162-8666

Tokyo Women's Medical University (TWMU), Tokyo

120-752

Yonsei University Medical Center, Seoul

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT01827904 - ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors | Biotech Hunter | Biotech Hunter